Genmab A/S (GMAB)
26.33
-0.71
(-2.63%)
USD |
NASDAQ |
May 29, 16:00
26.34
+0.02
(+0.06%)
After-Hours: 20:00
Genmab EPS Diluted (Quarterly) : 0.0833 for March 31, 2026
EPS Diluted (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
EPS Diluted (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
EPS Diluted (Quarterly) Benchmarks
| Ascendis Pharma A/S | 11.41 |
| Zealand Pharma A/S | -0.8738 |
| Bavarian Nordic A/S | 0.0115 |
| Evaxion AS | -0.4366 |
| Johnson & Johnson | 2.141 |
EPS Diluted (Quarterly) Related Metrics
| Net Income (Quarterly) | 53.20M |
| Revenue (Quarterly) | 899.32M |
| Total Expenses (Quarterly) | 846.12M |
| Enterprise Value | 20.05B |
| Gross Profit Margin (Quarterly) | 92.75% |
| Profit Margin (Quarterly) | 5.92% |
| Earnings Yield | 5.04% |
| Operating Earnings Yield | 7.70% |
| Normalized Earnings Yield | 5.955 |